I try investing a lot in smaller pharma companies... and they are hammered by the big ones. Not on innovation, but on marketing.
I disagree about NHS type system, that reduces access. A healthy mix is required, though.
A lot of upfront costs are also footed by users and government/non-government funds. And a lot more of those costs are due to government regulation and essential insurance at development.
Pharmaceutics researchers aren't exactly rich, btw. Your dentist probably makes more than many researchers of life saving drugs.
I disagree about NHS type system, that reduces access. A healthy mix is required, though.
A lot of upfront costs are also footed by users and government/non-government funds. And a lot more of those costs are due to government regulation and essential insurance at development.
Pharmaceutics researchers aren't exactly rich, btw. Your dentist probably makes more than many researchers of life saving drugs.